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ABSTRACT 
Objective: Three simple, rapid, accurate and precise spectrophotometric methods have been developed for the simultaneous estimation of 
atovaquone and proguanil hydrochloride in pharmaceutical preparations.  
Methods: The determination of drugs was carried out using the first order derivative, absorbance-ratio and bivariate spectrophotometric methods. 
The methods were validated for their linearity, accuracy and precision, recovery and ruggedness according to the ICH guidelines. 
Results: The linearity was established in the concentration range of 1.0-10 µg/ml for atovaquone and 0.5-8.0 µg/ml for proguanil hydrochloride by 
all three methods. The limit of detection (LOD) and the limit of quantitation (LOQ) of the methods varied from 0.252 to 0.270 µg/ml and 0.764 to 
0.825 µg/ml for atovaquone and 0.119 to 0.156 µg/ml and 0.361 to 472 µg/ml for proguanil hydrochloride respectively. The intra-and inter-batch 
accuracy (% recovery) and precision (% RSD) ranged from 99.16 to 101.05 % and 0.603 to 1.048 for atovaquone and 99.74 to 101.12 % and 0.593 
to 1.001 for proguanil respectively. 
Conclusion: The proposed methods were applied to a pharmaceutical formulation with acceptable accuracy and precision without any interference 
from commonly used excipients and additives. The results show that all three methods are comparable, cost effective and rapid and thus can be 
readily used in quality control labs for routine analysis of these drugs. 




1,4-naphthalene dione, ATQ] is chemically similar to ubiquinone, 
which plays an essential role in mediating electron transfer between 
mitochondrial respiratory enzyme complexes. It is a selective 
inhibitor of parasite mitochondrial electron transport, and is also 
reported that ATQ disturbs the mitochondrial membrane potential 
of Plasmodium falciparum [1]. It was developed by the Wellcome 
Laboratories in the 1980s as an antimalarial drug, a rare venture for 
a large pharmaceutical company [2].  
However, a 30% failure rate with ATQ was unacceptable, leading to 
a search for a synergistic drug. Combination with proguanil, an 
antimalarial of long-standing use, resulted in close to complete cure 
rate with no evidence for recrudescence [3]. Proguanil [1-(p-
chlorophenyl)-5-isopropylbiguanide, PRG] is a pro drug which is 
converted by the hepatic cytochrome P-450 isoenzyme to its active 
metabolite, cycloguanil and the inactive metabolite, 1-(4-
chlorophenyl) biguanide [4]. PRG was found to enhance significantly 
the ability of atovaquone to collapse mitochondrial trans-membrane 
potential. In large clinical studies, the fixed dose combination of ATQ 
and PRG has been shown to give improved outcomes over single 
dose formulations of either ATQ or PRG [5]. The synergistic fixed 
dose combination of ATQ and PRG has been approved by the US 
Food and Drug Administration (FDA) and European Medicines 
Agency for the treatment of acute, uncomplicated Plasmodium 
Falciparum malaria. In addition it has been shown that this 
combination is of grave importance in areas where the drugs 
chloroquine, halofantrine, mefloquine and amodiaquine may have 
unacceptable failure rates, presumably due to drug resistance [5, 6]. 
There have been very few reports on the estimation of ATQ either 
from fixed dose formulation or biological specimens and are mainly 
based on chromatographic techniques [7]. A differential pulse 
polarographic method is described for the determination of ATQ in 
its pharmaceutical formulations [8]. ATQ has been also estimated 
from serum samples using a capillary zone electrophoresis method 
[9]. Nevertheless, quite less efforts have been devoted to study PRG 
in pharmaceutical formulations [10, 11]. PRG along with other 
drugs/metabolites has been quantified from biological specimens 
using micellar electro kinetic chromatography [12], HPLC [13, 14] 
and LC-MS [15]. Several non-chromatographic methods for PRG are 
also available which include spectro fluorimetry [16], titrimetry [17, 
18], and microbially [19]; however, some of them lack both 
specificity and sensitivity and thus are of limited use for the 
simultaneous analysis with ATQ. Adewuyi et al. [20] have reported 
the use of sodium benzoxazole-2-sulphonate as a derivatizing 
reagent for the determination of PRG using HPLC. Recently, a 
renewable silver amalgam film electrode has been developed [21] 
for the estimation of PRG.  
There are some reports on chromatographic methods for 
simultaneous determination of ATQ and PRG; however they require 
different approaches to conventional liquid chromatography [22, 
23]. So far there have been no reports on the use of 
spectrophotometry for the simultaneous estimation of ATQ and PRG. 
The primary objective of the present study was to develop simple 
UV-Visible spectrophotometry based methods to quantify these 
drugs from their pharmaceutical preparation for routine analysis in 
quality control labs.  
MATERIALS AND METHODS 
Chemicals and materials  
Reference standards of atovaquone (ATQ, 98.74 %) and proguanil 
hydrochloride (PRG, 99.16 %) were purchased from Clear synth 
Laboratories Pvt. Ltd., Mumbai, India. Spectroscopic grade methanol 
was obtained from E. Merck, Mumbai, India. Twenty tablets of the 
proposed binary drug combination i.e. Malarone® (GlaxoSmithKline 
USA, 250 mg ATQ and 100 mg PRG) were commercially purchased 
from a local medical store.  
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Instrumentation and analysis conditions  
A Jasco V-570 double beam UV-Visible spectro photometer (Easton, 
MD) with matched 10 mm quartz cells was used for spectral 
measurements. The wavelength accuracy was within±0.5 nm, and a 
bandwidth of 1 nm was kept for all the methods. Data processing 
was done with Spectra manager software version 1.53.01.  
A scan speed of 400 nm/min was used to record the spectra. 
Weighing of samples was done on a Sartorius GD503 (Bradford, MA, 
USA) analytical balance having a readability of 0.0001 g. For 
studying the ruggedness of the methods, Shimadzu UV-1700 UV-
Visible Spectrophotometer (Tokyo, Japan) was also used.  
Stock solutions 
Separate stock solutions of ATQ and PRG equivalent to 200 μg/ml 
were prepared by dissolving carefully weighed amount i.e. 20 mg of 
each reference standard in 100 mL methanol.  
Spectral characteristics of analytes 
The zero-order absorption spectrum for 5.0 μg/ml of ATQ and PRG 
were recorded against methanol as a blank over 200–400 nm 
wavelength range.  
Construction of calibration curves 
Calibration standards were prepared in the concentration range of 
1.0–10.0 µg/ml for ATQ and 0.5–8.0 µg/ml for PRG from standard 
stock solutions (200 µg/ml) in two separate series of 10 mL 
volumetric flasks in methanol. The spectra of these standard 
solutions were recorded from 200 to 400 nm wavelength range.  
Derivative spectrophotometric method 
In our present work, the zero order absorption spectra were 
recorded for 5.0 μg/ml of ATQ and PRG, using methanol as a blank 
over 200–400 nm wavelength range. These zero order spectra of 
ATQ and PRG were treated to obtain corresponding first derivative 
spectra with an inter-point distance of 5 nm and scaling factor of 10. 
Using memory channels the zero and first order derivative spectra 
of both the drugs were overlaid for wave length selection and data 
treatment.  
The absorbance spectra of pure ATQ and PRG were recorded in a 
wavelength range of 200-400 nm within the range of 1.0-10.0 μg/ml 
for ATQ and 0.5-8.0 μg/ml for PRG and the first derivative spectra 
were obtained using Spectra manager version 1.53.01 software. Using 
these first derivative spectra, the regression equations for ATQ and 
PRG were calculated at 216.0 nm and 277.0 nm respectively. These 
wavelengths correspond to the zero crossing points in the derivative 
spectra of PRG and ATQ respectively. The quantification of drugs was 
performed using these regression equations and the derivative 
response of the pharmaceutical sample solution.  
Absorbance ratio method 
In order to construct two regression lines, two series of solutions were 
prepared and the absorbance values were measured at 221.0 (λmax of 
ATQ), 258.0 (λmax of PRG) and 277.0 nm (iso absorptive point, λiso
(a) Series 1: (for ATQ): Five aliquots equivalent to 10, 20, 30, 40 and 
50 µg of ATQ respectively were transferred to a series of 10-mL 
measuring flasks, containing an aliquot equivalent to 25 µg of PRG. 
Each flask was diluted to volume with methanol. The absorbance of 
each solution was measured at 221.0 nm and 277.0 nm. The relative 
absorbance (Q
). 
ATQ=AATQ/Aiso) and the corresponding relative 
concentration (CATQ/{CATQ+CPRG
(b) Series 2: (for PRG): Five aliquots equivalent to 10, 15, 25, 40 and 
60 µg of PRG respectively was transferred to a series of 10-mL 
measuring flasks, containing an aliquot equivalent to 30 µg of ATQ. 
Each flask was diluted to volume with methanol. The absorbance of 
each solution was measured at 258.0 nm and 277.0 nm. The relative 
absorbance (Q
}) was plotted and the regression 
equation for ATQ was computed.  
PRG=APRG/Aiso) and the corresponding relative 
concentration (CPRG/{CATQ+CPRG
Bivariate method 
}) was plotted and the regression 
equation for PRG was computed.  
Standard solutions covering the range of 1.0-10 μg/ml and 0.5-8.0 
μg/ml were prepared for ATQ and PRG respectively and the spectra 
was acquired from 200 to 300 nm and stored on computer and the 
regression equations were computed at 221.0 and 265.0 nm. 
Thereafter the solutions prepared from synthetic laboratory 
mixtures and pharmaceutical formulations were scanned for 
absorbance values and the regression parameters were used to 
resolve equations for CATQ and CPRG
Method validation parameters 
. 
All the proposed spectrophotometric methods were validated as per 
ICH guidelines for linearity, accuracy, precision, specificity, recovery 
and ruggedness [24].  
Linearity 
The linearity of each method was ascertained by analyzing five 
calibration standards for absorbance-ratio method and seven 
calibration standards for other methods within the range of 1.0-10.0 
μg/ml for ATQ and 0.5-8.0 μg/ml for PRG. The analytical response of 
each method was plotted against the concentration of each drug, and 
the slope, intercept and correlation coefficient were calculated. For 
an acceptable analytical method r2
Limit of detection and quantitation 
 must be ≥ 0.99.  
The sensitivity of each method was evaluated in terms of limit of 
detection (LOD) and limit of quantitation (LOQ). LOD and LOQ were 
calculated according to the ICH guidelines [24], using the standard 
deviation of the response. For this purpose, 1.0 μg/ml solutions of 
ATQ and PRG, was analyzed in three replicates; the standard 
deviation was calculated and the LOD and LOQ were evaluated using 







Accuracy and precision 
Intra and inter-batch accuracy and precision were evaluated by 
carrying out measurements of three replicate samples at 80 %, 100 
% and 120 % levels to that of the anticipated amount of the drugs in 
the sample solution on the same day and on three consecutive days 
respectively. The concentration values for known standards were 
calculated as % recovery and the precision of the method was 
reported in terms of percent relative standard deviation (% RSD). 
The methods were considered reproducible if the results were 
within the recommended range [24]. 
Selectivity and ruggedness 
The selectivity of the methods was established by analysis of the 
laboratory prepared standard mixtures. The interference due to 
commonly used excipients was also evaluated using the standard 
addition method (at 80 %, 100 % and 120 % levels to that of the 
amount in the sample). Known aliquots from the standard solutions 
of both the drugs were spiked into a pre-analyzed standard sample 
solution. For both the solutions, the amounts recovered were 
calculated and expressed in terms of mean recovery based on ICH 
guidelines for the assessment of the selectivity [24]. The ruggedness 
of the method was evaluated by analyzing standard samples of both 
the drugs and their combinations on two different 
spectrophotometers and also by using methanol obtained from two 
different sources. The methods were considered rugged for the 
proposed application if the % RSD were within the acceptable range. 
Analysis of marketed formulations 
To ascertain the applicability of the developed methods, they were 
used for the quantitation of these drugs in their marketed combined 
dosage form. Twenty tablets of MALARONE® were weighed and 
ground to fine powder. A quantity of the powder equivalent to 12.5 
mg ATQ and 5.0 mg PRG was accurately weighed and transferred to 
a 100 mL volumetric flask. To this 60 mL methanol was added, 
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sonicated for 15 min and briefly vortexed for the few seconds. The 
solution was filtered through Whatman filter paper 41 and the 
volume made up to 100 mL using methanol to give a final solution 
containing 125.0 μg/ml ATQ and 50.0 μg/ml PRG respectively. The 
working solutions were prepared by appropriate dilution of these 
stock solutions with methanol. 
RESULTS AND DISCUSSION 
Method development 
Derivative spectrophotometric method [25, 26] 
Adequate separation of overlapping peaks can be achieved by 
correct selection of derivative order. The zero order spectra for both 
ATQ and PRG showed intense overlapping as evident in fig. 1. 
 
 
Fig. 1: Zero order absorbance spectra for atovaquone (5.0 
μg/ml) and proguanil (5.0 μg/ml) in methanol 
 
Optimal derivative order is a function of signal height and the 
distance between maxima in basic spectrum. Several manipulations 
were made to enable the mixture resolution using first, second and 
third derivative of the absorption spectra with an inter-point 
distance of 5 nm and scaling factor of 10. Using memory channels, 
the zero, first, second and third order derivative spectra of both the 
drugs (5.0 μg/ml of each) were overlapped for wavelength selection 
and data treatment. First order derivative spectra (1
 
Fig. 2: First order absorbance spectra for (A) Atovaquone (1.0-
10.0 μg/ml) and (B) Proguanil (0.5-8.0 μg/ml) 
 
ATQ was determined at 216.0 nm without significant interference 
due to PRG. Since ATQ showed negligible contribution at 277.0 nm, 
PRG was accurately determined at this wavelength.  
Two calibration curves were established for both the drugs using the 
analytical response at respective zero crossing points and a straight 
line curve was observed in the concentration range of 1.0-10.0 
μg/ml for ATQ and 0.5–8.0 μg/ml for PRG as shown in fig. 3. The 
regression equations and correlation coefficients for both the drugs 
were calculated using equations 3 and 4,  
−dA
dλ�  =  0.0046 CATQ + 0.00036 (r
2 =  0.9998) at 216 nm (3) 
D) afforded the 
highest accuracy and detection limits compared to second and third 
order spectra and hence was selected for the analysis. In contrast to 
zero-order spectra, first derivative spectra showed enhanced 
resolution in terms of zero crossing point. The first derivative 
spectra were obtained using Δλ=5 nm and a scaling factor of 10 for 
the calibration standards of both the drugs (fig. 2). 
dA
dλ�  =  0.00615 CPRG + 0.00008 (r
2 =  0.9996) at 277 nm (4) 
  
 
Fig. 3: Calibration curves of (A) Atovaquone (1.0-10.0 μg/ml) and (B) Proguanil (0.5-8.0 μg/ml) using the proposed first derivative method 
 
Absorbance ratio method [27]: This method is based on the selection 






× 103 (5) 
. The mathematical 
treatment for the method can be expressed through equations 5 and 






× 103 (6) 
where, Q1 is the absorbance ratio (A1/Aiso) for the first component 
(ATQ); Q2 is the absorbance ratio (A2/Aiso) for the second 
component (PRG); C1 and C2 are the concentrations of ATQ and PRG 
respectively; Aiso is the absorbance at isoabsorptive point; aiso is the 
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absorptivity at iso absorptive point which equals to 
(Aiso/{C 1+C 2}); a 1 is the slope of regression equation (Q 1 vs. 
C 1/{C 1+C2}); a2 is the slope of the regression equation ({Q 2 vs. 
C 2/{C 1+C2}); b 1 and b 2 are intercept values of these regression 
equations and A 1 and A 2 denotes the absorbance values of the 
mixture measured at λ 1 and λ 2 
The zero order absorption spectra of ATQ (5 μg/ml) and PRG (5 
μg/ml) showed an iso absorptive point at 277.0 nm (fig. 1). The 
synthetic mixtures of the components were prepared as described 
earlier and the absorbance values were measured at 221.0 nm (λ
respectively.  
max 
of ATQ), 258.0 nm (λmax of PRG), and 277.0 nm (λ iso
Q1  =  0.274 �
CATQ
CATQ+CPRG
�+ 1.178 (r² =  0.9997) (7) 
). A linear 
relation between the absorbance ratio value of the binary mixture 
and the relative concentration of such a mixture was established as 
shown in fig.4. There was good linearity between the two variables 
as evident from the correlation coefficients values in the following 
equations 7 and 8,  
Q2  =  1.156 �
CPRG
CATQ+CPRG
�+ 1.094 (r² =  0.9995) (8) 
From the above regression equations 7 and 8, the values of slopes 
and intercepts were obtained and used to resolve equations 5 and 6 
in order to determine the concentration of ATQ and PRG. 
 
 
Fig. 4: Plot of (A) Q1 vs. C1/(C1+C2) and (B) Q2 vs. C2/(C1+C2
 
Bivariate method: This is different from Vierordt’s method [28] in 
that it determines the linear regression parameters for the different 
set of wavelengths other than respective absorbance maxima [29]. 
To assure the highest sensitivity and selectivity a suitable pair of 
wavelengths was optimized by using Kaiser’s method of matrix 
determinant [30]. The slope values of the regression line were 
determined for both the components (drugs) at the pre-selected 
wavelengths and a series of sensitivity matrices K was created for 
every pair of pre-selected wavelengths as shown below,  
𝐾𝐾 = �
𝑚𝑚𝐴𝐴𝐴𝐴𝐴𝐴1 𝑚𝑚𝑃𝑃𝑃𝑃𝑃𝑃1
𝑚𝑚𝐴𝐴𝐴𝐴𝐴𝐴2 𝑚𝑚𝑃𝑃𝑃𝑃𝑃𝑃2� (9) 
) for Atovaquone and Proguanil using absorbance-ratio method 
Where, mATQ1, mATQ2 and mPRG1, mPRG2 are the slopes for components 
ATQ and PRG at two selected wavelengths (λ1 and λ2
Firstly, nine wavelengths were considered for the selection of a set 
of wavelengths using the method of Kaiser [30]. By analyzing 
calibration standards at selected wavelengths, the slope values of 
the linear regression (m
), which are 
considered as the sensitivity parameters. Absolute matrix 
determinant values were calculated for each set of wavelength and 
the set for which the highest determinant values were obtained, was 
selected for the analysis.  
Ai  and mBi
 
) were estimated for both the 
analytes. Using the obtained data, the sensitivity matrices were 
formed for each set of wavelength and the respective absolute 
matrix determinant values were acquired. From the results obtained 
as shown in table 1, 221.0 nm and 265.0 nm were used for sensitive 
bivariate determination of ATQ and PRG. 
Table 1: Application of the method of Kaiser for the selection of wavelength set 
λ1/λ2 nm 
a 
210 221 230 240 252 258 265 280 290 
210 0.0 46.1 12.7 6.2 2.0 38.8 48.7 32.6 33.4 
221  0.0 58.6 55.9 73.5 112.5 113.0 2.0 19.9 
230   0.0 7.6 17.7 18.2 30.6 40.9 36.9 
240    0.0 7.3 32.0 43.9 39.3 37.8 
252     0.0 56.8 72.6 51.9 52.3 
258      0.0 23.8 77.9 64.7 
265       0.0 77.8 60.8 
280        0.0 12.6 
290         0.0 
a The absolute values of determinants of sensitivity is K × 10-5 
 
Thereafter, absorbance values were obtained for standard solutions 
of ATQ and PRG within their linearity ranges, and the resultant 
linear regression calibration formula used for the bivariate 
algorithm are presented as,  
y = 0.109137 ∙ CATQ + 0.008484, at 221 nm (10) 
y = 0.059443 ∙ CATQ + 0.004621, at 265 nm (11) 
y = 0.088781 ∙ CPRG + 0.001208, at 221 nm (12) 
y = 0.151912 ∙ CPRG + 0.002067, at 265 nm (13) 
The above equations 10-13 was solved for ATQ and PRG, and were 
utilized to determine the amount of the drugs present in the 
mixture.  
Method validation results 
Linearity: For each spectrophotometric method, three calibration 
curves were prepared by analyzing five/seven non-zero 
concentrations to define the linearity of the methods. The calibration 
curves were linear in the range of 1.0-10.0 μg/ml and 0.5-8.0 μg/ml 
for ATQ and PRG, respectively. The detailed summary of linearity 
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along with the regression equation, correlation coefficient, LOD and 
LOQ for the selected drug combination is presented in table 2. The 
high values of correlation coefficient for both the drugs demonstrate 
good linearity of the proposed methods and their fitness for analysis. 
Limits of detection and quantification: Limit of detection (LOD) and 
limit of quantification (LOQ) were calculated according to the ICH 
guidelines [24]. Standard deviation (SD) was calculated by triplicate 
analysis of pure standard solutions containing 1.0 μg/ml of ATQ and 
PRG respectively. The sensitivity of the proposed method can be 
confirmed by the low LOD and LOQ values as shown in table 2.
  
Table 2: Regression parameters obtained for the proposed spectrophotometric methods 
Drug Linearity range (μg/ml) Slope Intercept  Correlation coefficient (r2) LOD (μg/ml) LOQ (μg/ml) 
Derivative spectrophotometric method 
ATQ 1.0-10.0 0.0046 0.00004 0.9998 0.270 0.825 
PRG 0.5-8.0 0.0062 0.00008 0.9996 0.156 0.472 
Absorbance ratio method 
ATQ 1.0-10.0 0.2744 1.1777 0.9997 0.262 0.795 
PRG 0.5-8.0 1.1556 1.0936 0.9995 0.119 0.361 
Bivariate method 
ATQ 1.0-10.0 0.1091 0.0085 0.9998 0.252 0.764 
PRG 0.5-8.0 0.1519 0.0021 0.9996 0.134 0.407 
 
Accuracy and precision 
Intra-and inter-batch accuracy and precision were calculated by 
analyzing standard samples at three concentration levels by using 
the same procedure as described previously. The concentrations 
were calculated using the corresponding regression equations. A 
concise summary of the obtained accuracy and precision values are 
given in table 3, which indicates that the % RSD were within the 
acceptable range for both the drugs. The precision values expressed 
as % RSD were less than 2 %, while the accuracy ranged from 99.16 
to 101.12 % for both the drugs. 
Selectivity and ruggedness 
Selectivity of the developed method was confirmed by analysis of 
laboratory prepared mixtures in three replicates. Standard mixtures 
were prepared at three different concentration levels and the 
percentage drug content was calculated. Here, the % mean 
recoveries were considered to confirm the accuracy of a method and 
the detailed results obtained by applying the standard addition 
technique are shown in table 4.  
All three spectrophotometric methods were found to be selective 
for the proposed application using methanol as the solvent. In the 
ruggedness study with different instrumentation and solvent source, 
no significant changes in the response of the methods were found 
for both the drugs. The % RSD for all the developed 
spectrophotometric methods was constantly less than 2 %.  
Stability of solutions 
ATQ and PRG stock and calibration solutions remained unaffected 
for a minimum period of 2 weeks when stored at 4 ºC. There was 
practically no change in concentration as evident from 
spectrophotometric measurements and no degradation occurred 
under refrigerated conditions during the storage period. 
 
Table 3: Accuracy and precision results of atovaquone and proguanil in bulk form using the proposed methods 
Amount added (µg/ml) Intra-batcha Inter-batchb 
% Recovery (% RSD) % Recovery (% RSD) 






















99.16 (0.741) 100.17 (0.851) 100.33 
(0.807) 
Proguanil 
1.6 99.86 (0.603) 100.48 (0.906) 100.39 (0.562) 100.27 (0.766) 100.13 (0.794) 100.16 
(0.646) 
2.0 100.48 (0.754) 100.54 (0.798) 99.74 (0.727) 101.12 (1.001) 100.00 (0.987) 100.47 
(0.911) 
2.4 99.76 (0.820) 100.37 (0.593) 99.94 (0.665) 99.78 (0.613 99.78 (0.692) 99.99 
(0.717) 
aMean values obtained in triplicate on the same day; bMean values obtained in triplicate on three consecutive days; cFirst derivative 
spectrophotometric method; dAbsorbance ratio method; eBivariate spectrophotometric method  
 
Table 4: Recovery of atovaquone and proguanil by the standard addition technique 
Drug 
 
Amount taken (μg/ml) Amount added 
(μg/ml) 
% Mean recovery (±SD), n = 3 
1DSMa ARMb BSMc 
ATQ 2.5 4.0 100.37±0.84 100.97±0.77 100.45±0.58 
2.5 5.0 100.29±0.70 100.21±1.06 99.28±0.72 
2.5 6.0 99.71±0.65 99.80±0.71 99.01±0.82 
PRG 1.0 1.6 99.55±0.97 99.50±0.75 99.83±0.61 
1.0 2.0 100.75±0.59 98.84±0.95 100.25±60 
1.0 2.4 99.54±0.80 99.39±1.17 99.65±0.69 
aFirst derivative spectrophotometric method; bAbsorbance ratio method; cBivariate spectrophotometric method 
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Table 5: Analysis of marketed formulation MALARONE® by the proposed methods 
Drug Amount claimed (mg) % Mean recovery (±SD), n = 3 
  First derivative Absorbance ratio Bivariate 
Atovaquone 250 100.75±1.02 99.68±0.91 100.19±0.52 
Proguanil 100 100.29±0.84 99.26±0.93 99.42±0.79 
 
Analysis of the marketed formulation MALARONE® by the 
proposed methods 
The proposed spectrophotometric methods were successfully 
applied for the determination of selected drugs in the marketed 
formulation. Recoveries were calculated using regression analysis 
and also by the standard addition method. The results obtained 
were precise and in good agreement with the labeled claim as 
apparent from the satisfactory values of recovery and % RSD shown 
in table 5. Further, the recovery studies with all the methods 
indicate that there was no interference from the excipients 
commonly present in the tablet formulation. 
Comparison of the method performance with those of reported 
method 
The developed methods offer significant advantages over few reported 
analytical methods [8, 16-19] i.e. high sensitivity, adequate accuracy 
and precision. Though the sensitivity is less compared to advanced 
methodologies based on electrophoresis [9], chromatography [7, 10, 
11-13, 15, 20] and voltammetry techniques [8, 21], these methods are 
more preferable owing to their simplicity and ease of analysis. In 
addition, the major advantage is that they do not require any type of 
expensive instrumentation. They can be operated using a simple 
double beam UV-Visible spectrophotometer which can be easily found 
in any chemical or quality control laboratory.  
The only available methods for simultaneous quantitation of ATQ 
and PRG require tedious and time consuming modifications to 
existing HPLC equipment [22, 23]. On the other hand, the present 
methods do not need any such modifications and the only essential 
requirement is the computational programs for data processing. 
Though the results of HPLC methods are to some extent better 
than the present methods in terms of sensitivity and selectivity, 
but the long analytical run time of about 20 min makes it less 
preferable choice for routine quality control laboratories. 
Moreover due to the large difference in their lipophilicity it is 
quite difficult to achieve a rapid simultaneous elution and 
quantitation [22, 23].  
However, use of spectrophotometry for such task seems fairly easy 
as the difference in their lipophilic nature does not affect their 
spectral characteristics, and hence could be computationally 
resolved from their combination spectra. In the present study, this 
has been achieved by using the first derivative, absorbance ratio 
and bivariate methods. Additionally, the method developed by 
Bergqvist and Hopstadius [22] mainly focused on method 
development, and less on the validation parameter. On the 
contrary, the present methods were validated following the ICH 
guidelines [24] and then applied for the analysis of drugs from 
their pharmaceutical preparations. Furthermore, the validation 
results were found comparable to the results of Lindegårdh et al. 
[23].  
CONCLUSION 
In the present study three spectrophotometry based methods 
namely derivative spectrophotometry, absorbance ratio method, 
and bivariate method was investigated for the simultaneous analysis 
of atovaquone and proguanil. By careful selection of the optimum 
wavelength, it was possible to determine their concentration in 
binary mixtures. The developed methods were suitably validated 
following the standard guidelines, and were successfully applied for 
the quantitation of these drugs in their pharmaceutical formulation. 
All three methods were comparable in terms of accuracy 
(recoveries) and precision for both the analytes. Finally, based on 
the overall performance of these methods they can be readily 
applied in quality control laboratories which do not have 
sophisticated instruments like HPLC. 
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